GSK
GSK plc · Healthcare · Drug Manufacturers - General
Input momentum (manajer yang sebanding):
keluasan pemegang -6.2% ·
aliran saham +6.0% ·
posisi baru bersih -6.7%
· formula
Akumulasi terkonsentrasi: saham yang meningkat di antara lebih sedikit pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q4 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 163.18K | $7.64M | n/a | n/a |
| Q2 2026 | 117 | +1 | 291.89M | $15.17B | +8 | −6 |
| Q1 2026 | 116 | 0 | 315.42M | $17.28B | +8 | −8 |
| Q4 2025 | 115 | +4 | 328.16M | $15.98B | +4 | n/a |
| Q3 2025 | 18 | -1 | 242.57M | $10.47B | +1 | −3 |
| Q2 2025 | 17 | +1 | 220.73M | $8.48B | +2 | −1 |
| Q1 2025 | 14 | -1 | 157.56M | $6.11B | n/a | −1 |
| Q4 2024 | 15 | -1 | 135.53M | $4.59B | n/a | −1 |
| Q3 2024 | 15 | +3 | 120.78M | $4.99B | +3 | n/a |
| Q2 2024 | 12 | n/a | 118.47M | $4.56B | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 68.44M | +0.5% | $2.31B | 1.3% | ▲ Add | 3 | SEC ↗ |
| 2 | PRIMECAP Management ✦ | 25.26M | +70.1% | $854.35M | 0.7% | ▲ Add | 3 | SEC ↗ |
| 3 | Fisher Asset Management ✦ | 18.84M | +1.4% | $637.06M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 7.57M | +0.5% | $255.91M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 5 | State Street Global Advisors ✦ (pasif) | 7.03M | n/a | $240.32M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 2.76M | +18.0% | $93.18M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 7 | Bridgewater Associates ✦ | 2.25M | +132.7% | $76.02M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 2.09M | +10.0% | $70.82M | 0.0% | ▲ Add | 3 | SEC ↗ ×6 |
| 9 | Two Sigma Investments ✦ | 574.75K | +602.5% | $19.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Arrowstreet Capital ✦ | 218.26K | -94.4% | $7.38M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 183.81K | -68.2% | $6.22M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 114.11K | -7.1% | $3.86M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Tweedy, Browne ✦ | 93.82K | -13.2% | $3.17M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 14 | Millennium Management ✦ | 91.56K | -93.7% | $3.10M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 21.82K | -20.5% | $737,922 | 0.0% | ▼ Trim | 3 | SEC ↗ ×3 |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Marshall Wace | $11.58M | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1,022 pemegang, 373.63M saham, $18.86B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.